These newer therapies, including Rybelsus, belong to a class of drugs called GLP-1 mimics . Originally intended for treating type 2 diabetes , they operate by encouraging the body to secrete sufficient insulin production and reducing increased blood sugar levels. Additionally , their capacity to encourage weight management has resulted to increased